What Vesalius Ventures does

Vesalius Ventures, Inc. is a private venture capital firm headquartered in Houston, Texas, founded in June 2002 with backing from Vanguard Ventures, Fremont Ventures, and Guidant Corporation (later joined by Sevin Rosen Funds in 2003 and partnered with Opal Ventures in 2008). The firm specializes in early to mid-stage healthcare technology investments, with a core focus on medical informatics, telemedicine, and the convergence of healthcare, telecommunications, and information technology. Since inception the firm has reviewed over 500 companies in its deal-flow pipeline and holds portfolio positions across cardiac monitoring (Artella Solutions, Monebo Technologies), digital therapeutics (Freespira), genomics (MolecularMatch), sepsis protocols (Luminare), secure healthcare communications (RMD Networks), chronic care management (Health Hero Network), personal health management (LifeOnKey), and tolling technology (TapnPay).

Vesalius operates through four integrated entities: Vesalius Accelerator (core early-stage technology investing), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment targeting Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services for healthcare entities). The firm's revenue model is equity-driven, generating returns through capital appreciation and exits from portfolio investments, supplemented by advisory fees from the Health Advisors arm. The firm has reported no public revenue, fund size, or AUM figures, and operates with a lean team of 11-50 employees led by CEO and Managing Partner Dr. Bernard A. Harris, Jr. (former NASA astronaut, current board member at Raytheon Technologies, MassMutual, Solventum, and U.S. Physical Therapy) and COO Pamela R. Jones, MBA.

The firm's go-to-market is relationship-driven, relying on its founding partner network (Vanguard, Fremont, Guidant/Boston Scientific, Sevin Rosen, Opal Ventures) for deal sourcing, co-investment, and portfolio company support. As of 2025 the firm remains privately held with no disclosed IPO plans, and its most recent material corporate event was the 2025 TapnPay–Neology merger involving a portfolio company.

Name

Vesalius Ventures

Legal name

Vesalius Ventures, Inc.

Website

https://vesaliusventures.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Vesalius Ventures is a Houston-based venture capital firm founded in 2002 that invests in early to mid-stage healthcare technology companies, with a core focus on telemedicine, medical informatics, and the convergence of healthcare, telecommunications, and information technology.

Ownership category

akta.pro rank

Product category

Venture Capital Investment Services

NAICS

Portfolio Management and Investment Advice (523940), Management Consulting Services (54161)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital
• Healthcare investments
• Telemedicine advisory
• Medical informatics funding
• Early-stage growth capital

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Venture Capital Investment Returns: Vesalius Ventures generates returns through equity investments in early to mid-stage healthcare technology companies. The firm provides capital and management assistance to portfolio companies, with the goal of achieving above-market returns through successful exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Vesalius Ventures is a venture capital firm that invests equity capital and provides management assistance in early to mid-stage healthcare technology companies, with a specialization in medical informatics and telemedicine. Its activity is delivered through four entities: Vesalius Accelerator (sourcing and developing emerging healthcare technologies), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment of technologies into Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services to healthcare entities worldwide).

Product overview

Vesalius Ventures is a venture capital firm created for diversified investments, founded in 2002. The company operates through four distinct internal divisions: Vesalius Accelerator (early-stage technology investment), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international market expansion in Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services). The firm also maintains a portfolio of healthcare technology investments including TapnPay, Artella Solutions, The Able Channel, Freespira, Luminare, MolecularMatch, RMD Networks, Monebo Technologies, Health Hero Network, and LifeOnKey.

Differentiator

Problem solved

Functional benefit

Products and services

• Vesalius Accelerator Venture capital accelerator dedicated to supporting early-stage technologies that advance medicine; identifies promising technology, develops business opportunities, finances, and brings companies to market at the intersection of healthcare, telecommunication, and information technology. Targeted at founders and management teams of early to mid-stage healthcare technology companies.
• Vesalius Capital Group Investment entity exploiting opportunities in advanced technologies in clean tech, healthcare, information technology, and energy, focusing on early to mid-stage diversified investments using specialized financing strategies. Targeted at companies and projects requiring capital beyond the firm's core healthcare technology focus.
• Vesalius International International business development vehicle identifying opportunities in advanced technologies to support deployment of early-stage technologies internationally through the Vesalius accelerator model, with target markets in Asia, Middle East, and Africa. Targeted at technology companies seeking international market entry and at international partners seeking validated healthcare technologies.
• Vesalius Health Advisors Premier telemedicine advisory services company offering telemedicine expertise worldwide to healthcare entities of every type and size, with a team of renowned telemedicine experts focused on the clinical, financial, and technical aspects of telemedicine. Targeted at hospitals, clinics, providers, and other healthcare organizations evaluating or scaling telemedicine programs.

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Opal VenturesmajorStrategic or Co-development Partner · 1 January 2008Established partnership in 2008 to bring medical technologies from Israel and Europe to the US market. Opal Ventures is a healthcare dedicated private equity organization managing investment funds and building healthcare organizations, based and focused on the Israeli healthcare market.

Scale indicators3 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• OrbiMed Advisors: One of the largest healthcare-focused investment firms globally, investing across biopharma, medical devices, diagnostics, and digital health from early to late stage. Directly comparable to Vesalius as a healthcare-vertical specialist serving similar medtech and health-IT opportunities.
• SV Health Investors: Healthcare-only venture and growth equity firm investing in biotechnology, medical devices, and digital health. Directly comparable to Vesalius as a sector-specialist VC with a similarly vertical focus and similar stage orientation across medtech and health IT.
• ARCH Venture Partners: Early-stage venture firm investing in life sciences, physical sciences, and information technology with strong healthcare emphasis. Comparable to Vesalius through its early-stage, technology-driven healthcare investing and similar scientific-founder orientation.
• 5AM Ventures: Early-stage life sciences venture firm focused on building biotech, medical device, and platform companies. Comparable to Vesalius as a healthcare-specialist early-stage VC with similar founder-collaboration and incubation-style investing.
• Frazier Healthcare Partners: Healthcare-dedicated investment firm providing venture and growth capital to therapeutics, medical devices, and healthcare services. Comparable to Vesalius as a pure-play healthcare VC with overlapping portfolio themes in medtech and health services.
• Santé Ventures: Texas-based venture firm investing in early-stage healthcare and life sciences companies, including medical devices and digital health. Highly comparable to Vesalius as a healthcare-specialist early-stage VC with regional overlap in Houston/Texas.
• Health Catalyst Capital: Growth equity firm focused exclusively on healthcare information technology and services. Comparable to Vesalius through its digital health and health-IT investment focus, representing a slightly later-stage but directly thematic peer.

Broad incumbents

• New Enterprise Associates (NEA): Large multi-stage VC with a significant healthcare practice spanning medical devices, digital health, and biotech. Comparable to Vesalius through its healthcare investing activities, though NEA operates across technology and consumer as well, making it a broader incumbent in the venture space.
• Polaris Partners: Multi-stage venture firm with dedicated healthcare and technology practices, investing across biotech, medtech, and digital health. Comparable to Vesalius through its healthcare vertical, though it operates as a broader incumbent across multiple tech sectors.

Others

• Boston Scientific Ventures: Corporate venture arm of Boston Scientific, a founding corporate partner of Vesalius Ventures. Comparable as a strategic healthcare investor with direct medtech deal flow and potential co-investor or acquirer relationship with Vesalius portfolio companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vesalius-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vesalius Ventures